Merck KGaA (MRK)

Basic

  • Market Cap

    €69.63B

  • EV

    €78.08B

  • Shares Out

    434.78M

  • Revenue

    €21.43B

  • Employees

    63,297

Margins

  • Gross

    60.22%

  • EBITDA

    27.76%

  • Operating

    20.6%

  • Pre-Tax

    17.19%

  • Net

    13.5%

  • FCF

    9.26%

Returns (5Yr Avg)

  • ROA

    4.94%

  • ROE

    14.07%

  • ROCE

    10.29%

  • ROIC

    6.48%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €190.06

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    €49.32

  • Earnings (Dil)

    €6.66

  • FCF

    €4.57

  • Book Value

    €64.92

Growth (CAGR)

  • Rev 3Yr

    7.36%

  • Rev 5Yr

    7.98%

  • Rev 10Yr

    6.71%

  • Dil EPS 3Yr

    15.46%

  • Dil EPS 5Yr

    8.58%

  • Dil EPS 10Yr

    9.27%

  • Rev Fwd 2Yr

    -0.44%

  • EBITDA Fwd 2Yr

    -4.92%

  • EPS Fwd 2Yr

    -4.48%

  • EPS LT Growth Est

    7.65%

Dividends

  • Yield

  • Payout

    33.04%

  • DPS

    €2.2

  • DPS Growth 3Yr

    19.17%

  • DPS Growth 5Yr

    11.97%

  • DPS Growth 10Yr

    9.98%

  • DPS Growth Fwd 2Yr

    1.74%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Total Revenues

14,836.0

16,152.0

17,534.0

19,687.0

22,232.0

21,428.0

Total Revenues % Chg.

2.2%

8.9%

8.6%

12.3%

12.9%

-1.6%

Cost of Goods Sold, Total

5,342.0

5,951.0

6,782.0

7,325.0

8,495.0

8,525.0

Gross Profit

9,494.0

10,201.0

10,752.0

12,362.0

13,737.0

12,903.0

Selling General & Admin Expenses, Total

5,486.0

5,683.0

5,295.0

5,459.0

5,914.0

5,832.0

Stock-Based Compensation

15.0

-14.0

5.0

3.0

-7.0

-7.0

R&D Expenses

2,226.0

2,239.0

2,262.0

2,418.0

2,446.0

2,398.0

Other Operating Expenses

-211.0

-260.0

119.0

177.0

372.0

266.0

Other Operating Expenses, Total

7,516.0

7,648.0

7,681.0

8,057.0

8,725.0

8,489.0

Operating Income

1,978.0

2,553.0

3,071.0

4,305.0

5,012.0

4,414.0

Interest Expense, Total

-268.0

-403.0

-328.0

-244.0

-194.0

-258.0

Interest And Investment Income

55.0

66.0

39.0

46.0

71.0

127.0

Net Interest Expenses

-213.0

-337.0

-289.0

-198.0

-123.0

-131.0

Currency Exchange Gains (Loss)

-46.0

-86.0

-60.0

-34.0

-109.0

-109.0

Other Non Operating Income (Expenses)

2.0

-1.0

2.0

14.0

-3.0

-2.0

EBT, Excl. Unusual Items

1,721.0

2,129.0

2,724.0

4,087.0

4,777.0

4,172.0

Restructuring Charges

-46.0

-123.0

-170.0

-82.0

-199.0

-199.0

Merger & Related Restructuring Charges

-169.0

-217.0

-190.0

-59.0

-83.0

-83.0

Impairment of Goodwill

Gain (Loss) On Sale Of Investments

27.0

Gain (Loss) On Sale Of Assets

77.0

30.0

94.0

63.0

54.0

54.0

Asset Writedown

-58.0

-42.0

-183.0

-54.0

-232.0

-232.0

Legal Settlements

-53.0

-42.0

372.0

8.0

-6.0

-6.0

Other Unusual Items

-38.0

-16.0

-39.0

-23.0

-23.0

EBT, Incl. Unusual Items

1,461.0

1,735.0

2,631.0

3,924.0

4,288.0

3,683.0

Income Tax Expense

368.0

440.0

637.0

859.0

948.0

777.0

Earnings From Continuing Operations

1,093.0

1,295.0

1,994.0

3,065.0

3,340.0

2,906.0

Earnings Of Discontinued Operations

2,303.0

28.0

Minority Interest

-22.0

-3.0

-7.0

-10.0

-14.0

-13.0

Net Income

3,374.0

1,320.0

1,987.0

3,055.0

3,326.0

2,893.0

Net Income to Common Incl Extra Items

3,374.0

1,320.0

1,987.0

3,055.0

3,326.0

2,893.0

Net Income to Common Excl. Extra Items

1,071.0

1,292.0

1,987.0

3,055.0

3,326.0

2,893.0

Total Shares Outstanding

434.8

434.8

434.8

434.8

434.8

434.7

Weighted Avg. Shares Outstanding

434.8

434.8

434.8

434.8

434.8

434.4

Weighted Avg. Shares Outstanding Dil

434.8

434.8

434.8

434.8

434.8

434.4

EPS

7.8

3.0

4.6

7.0

7.6

6.7

EPS Diluted

7.8

3.0

4.6

7.0

7.6

6.7

EBITDA

3,675.0

4,234.0

4,591.0

5,787.0

6,556.0

5,947.9